Paracervical Block for Pain Control With Osmotic Dilator Placement

It is estimated that 1.21 million abortions were performed in 2008. Of these, approximately
11% occurred in the second trimester and 1.4% occurred after 21 weeks gestation. In the
United States, dilation and evacuation (D&E) is the most common method of terminating a
second trimester pregnancy with greater than 98% of second trimester abortions occurring by
D&E.

Pre-procedure cervical preparation decreases the incidence of complications associated with
D&E. Cervical dilators are often used prior to second trimester D&Es to aid in softening and
dilating the cervix. Typically, dilator placement occurs the day of the D&E or 1-2 days prior
and oftentimes occurs in an outpatient clinic setting without anesthesia readily available.
Many women experience moderate to severe discomfort with osmotic dilator insertion. Providers
use various methods to minimize this discomfort including PCB, non-steroidal
anti-inflammatory medications (NSAIDs), anxiolytics and narcotics. In particular, PCB and
NSAIDs are readily available in the clinic setting and can be used for this purpose. There
is, however, no data to support their efficacy in ameliorating the pain of dilator insertion.

Paracervical blocks are used commonly to decrease pain in abortion procedures and other
gynecological procedures. The PCB is thought to work primarily by blocking pain conduction
via Frankenhauser's plexus. As such, their effect may be most important in relieving the pain
associated with cervical dilation. In a recent randomized control trial, PCB prior to first
trimester surgical abortion was found to significantly reduce pain with cervical dilation and
uterine aspiration. Since osmotic dilator placement primarily involves cervical manipulation
and dilation, PCB may provide some pain relief over placebo. The research team proposes a
randomized controlled trial to evaluate the efficacy of a PCB in decreasing pain associated
with osmotic dilator placement. This trial will also provide information about the degree of
pain that women experience during osmotic dilator placement; information not previously
known.

Inclusion Criteria:

- voluntarily seeking surgical pregnancy termination

- gestational age on day of study 14w0d to 23w6d confirmed by pelvic ultrasound with a
viable pregnancy (no fetal demise diagnosed)

- eligible for second trimester D&E

- having osmotic dilators placed for cervical preparation the day prior to D&E

- able and willing to give informed consent and agree to terms of the study

- able to speak and read English or Spanish

Exclusion Criteria:

- took any prescription or illegal drugs 24 hours prior to the appointment

- drank alcohol 12 hours prior to the appointment

- took any over the counter pain medications 12 hours prior to the appointment other
than the standard 800mg of Ibuprofen

- contraindications to osmotic dilators

- allergic reaction or hypersensitivity to NSAIDs or lidocaine

- untreated acute cervicitis or pelvic inflammatory disease

- weight <100 pounds